Informed-money record

CBIO · CRESCENT BIOPHARMA, INC.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

1

Bearish filings

14

Named actors

15

Disclosed $ (bull / bear)

$18.2M / $1.2M

Recent disclosures

15 of 15 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-06-22Chief Executive Officer Brumm Joshua Tsold$761KSEC ↗
2026-06-22President and COO McNeill Jonathansold$370KSEC ↗
2026-06-22Chief Medical Officer Im Ellie Eunkyungsold$22KSEC ↗
2026-06-22See Remarks Bispham Barbara Harlinsold$22KSEC ↗
2026-06-22Chief Financial Officer Scalzo Richard Williamsold$20KSEC ↗
2026-06-22Chief Scientific Officer Pinkas Jansold$23KSEC ↗
2026-06-22See Remarks Lynch Ryansold$8KSEC ↗
2026-02-25General Counsel and Corporate Secretary Barbara Bispham Haleadopted a selling planSEC ↗
2026-02-25Treasurer, Senior Vice President of Finance and Chief Accounting Officer Ryan Lynchadopted a selling planSEC ↗
2026-02-25Chief Financial Officer Richard Scalzoadopted a selling planSEC ↗
2026-02-25Chief Executive Officer and member of the Company’s Board of Directors Joshua Brummadopted a selling planSEC ↗
2026-02-25Chief Operating Officer and President Jonathan McNeilladopted a selling planSEC ↗
2026-02-25Chief Medical Officer Ellie Imadopted a selling planSEC ↗
2026-02-25Chief Scientific Officer Jan Pinkasadopted a selling planSEC ↗
2025-12-04Director Harwin Peter Evanbought$18.2MSEC ↗

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals